Health.com16h
New Study Finds Many People with Diabetes Are Lacking Vitamin D and Magnesium
New research found that over half of people with type 2 diabetes in the Americas may be deficient in essential nutrients, ...
News Medical5d
Pain coping skills training reduces pain and improves quality of life for dialysis patients
People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...
ScienceAlert5d
Too Much Vitamin B6 Can Be Toxic. Here's What You Need to Know.
In recent weeks, reports have been circulating about severe reactions in people who've taken over-the-counter vitamin B6 ...
VRTX Gets FDA Nod for Non-Opioid Pain Drug Journavx, Shares Up
The FDA approves Vertex's non-opioid oral pain signal inhibitor, Journavx, for treating adults with moderate-to-severe acute pain. Shares rise.
Too Old to Operate5d
Exploring taVNS as a Treatment for CIPN
The following is a summary of “Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy,” published in the January 2025 issue of ...
FDA approves Vertex’s acute pain treatment Journavx
The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults ...
Many cancer patients experience nerve pain from chemo
Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.
Too Old to Operate7d
Association of hs-cTnT With Diabetic Lower Extremity Disease
The following is a summary of “Correlation between high-sensitivity cardiac troponin levels in diabetic patients’ serum and ...
Vertex Pharmaceuticals’ Suzetrigine: A Promising Opioid Alternative in Pain Management
Leerink Partners analyst David Risinger has reiterated their bullish stance on VRTX stock, giving a Buy rating yesterday.Invest with ...